CompletedNCT05472818
Brain imaging before and after cannabis abstinence in people with cannabis use disorder
About this title
Read the official source — NCT05472818Medication studyAges 18–75United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 75 years.
- Listed locations
- New HavenSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Study information
Study start dateStarted: April 12, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 51
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT05472818
- Official title
Show the full official title
SV2A Density Cannabis Use Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Did this study involve medication?
Yes. The study involved medication, including [11C]APP311.
Who was this study for?
Listed age limits: 18 years to 75 years.
